Apyx Medical Stock Price To Sales

APYX Stock

USD 1.45 0.03 2.11%

Apyx Medical fundamentals help investors to digest information that contributes to Apyx Medical's financial success or failures. It also enables traders to predict the movement of Apyx Stock. The fundamental analysis module provides a way to measure Apyx Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Apyx Medical stock.

		Last Reported	Projected for Next Year
	Price To Sales Ratio	1.73	1.65

Price To Sales Ratio is likely to drop to 1.65 in 2024.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Apyx Medical Company Price To Sales Analysis

Apyx Medical's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

P/S

MV Per Share

Revenue Per Share

More About Price To Sales | All Equity Analysis

Current Apyx Medical Price To Sales

1.09 X

Most of Apyx Medical's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Apyx Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Apyx Price To Sales Driver Correlations

Understanding the fundamental principles of building solid financial models for Apyx Medical is extremely important. It helps to project a fair market value of Apyx Stock properly, considering its historical fundamentals such as Price To Sales. Since Apyx Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Apyx Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Apyx Medical's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Good Will	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Long Term Debt	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.81	0.19	-0.6	0.15	0.67	0.66	-0.45	0.5	1.0	0.71	-0.72	-0.05	0.32	0.66	0.88	-0.58	0.71	-0.69	-0.89	0.92	0.96	0.43
Total Stockholder Equity	0.81		0.43	-0.77	0.63	0.29	0.45	-0.31	-0.1	0.82	0.54	-0.56	0.06	0.23	0.29	0.95	-0.56	0.5	-0.58	-0.74	0.89	0.82	-0.12
Current Deferred Revenue	0.19	0.43		-0.51	0.35	0.03	0.0	-0.26	-0.31	0.21	-0.02	0.02	-0.03	0.17	-0.12	0.27	0.08	0.15	-0.06	-0.07	0.26	0.17	-0.46
Net Debt	-0.6	-0.77	-0.51		-0.46	-0.35	-0.48	0.19	0.11	-0.61	-0.46	0.51	-0.16	-0.17	-0.48	-0.72	0.4	-0.44	0.46	0.61	-0.67	-0.6	0.2
Retained Earnings	0.15	0.63	0.35	-0.46		-0.49	-0.27	0.08	-0.68	0.16	-0.04	-0.01	0.09	-0.12	-0.4	0.51	-0.1	-0.3	-0.03	-0.07	0.42	0.29	-0.67
Accounts Payable	0.67	0.29	0.03	-0.35	-0.49		0.82	-0.35	0.71	0.67	0.6	-0.67	0.04	0.24	0.87	0.41	-0.42	0.82	-0.59	-0.74	0.46	0.55	0.62
Net Receivables	0.66	0.45	0.0	-0.48	-0.27	0.82		-0.3	0.45	0.66	0.74	-0.73	0.11	0.27	0.87	0.53	-0.57	0.83	-0.66	-0.82	0.51	0.56	0.4
Good Will	-0.45	-0.31	-0.26	0.19	0.08	-0.35	-0.3		-0.28	-0.38	-0.18	-0.14	0.78	-0.72	-0.3	-0.17	0.05	-0.18	0.12	0.16	-0.15	-0.22	-0.06
Total Liab	0.5	-0.1	-0.31	0.11	-0.68	0.71	0.45	-0.28		0.48	0.41	-0.39	-0.18	0.21	0.69	0.1	-0.14	0.49	-0.33	-0.41	0.25	0.41	0.92
Total Current Assets	1.0	0.82	0.21	-0.61	0.16	0.67	0.66	-0.38	0.48		0.71	-0.77	0.03	0.24	0.65	0.9	-0.6	0.72	-0.71	-0.9	0.94	0.97	0.42
Short Term Debt	0.71	0.54	-0.02	-0.46	-0.04	0.6	0.74	-0.18	0.41	0.71		-0.63	0.05	0.33	0.68	0.62	-0.56	0.71	-0.65	-0.81	0.67	0.69	0.46
Intangible Assets	-0.72	-0.56	0.02	0.51	-0.01	-0.67	-0.73	-0.14	-0.39	-0.77	-0.63		-0.58	0.27	-0.68	-0.76	0.63	-0.71	0.71	0.88	-0.77	-0.8	-0.4
Common Stock	-0.05	0.06	-0.03	-0.16	0.09	0.04	0.11	0.78	-0.18	0.03	0.05	-0.58		-0.82	-0.02	0.24	-0.38	0.19	-0.19	-0.2	0.18	0.15	-0.04
Property Plant Equipment	0.32	0.23	0.17	-0.17	-0.12	0.24	0.27	-0.72	0.21	0.24	0.33	0.27	-0.82		0.3	0.06	0.06	0.32	-0.17	-0.2	0.11	0.1	0.18
Long Term Debt	0.66	0.29	-0.12	-0.48	-0.4	0.87	0.87	-0.3	0.69	0.65	0.68	-0.68	-0.02	0.3		0.41	-0.33	0.72	-0.61	-0.77	0.47	0.56	0.58
Net Tangible Assets	0.88	0.95	0.27	-0.72	0.51	0.41	0.53	-0.17	0.1	0.9	0.62	-0.76	0.24	0.06	0.41		-0.67	0.58	-0.66	-0.84	0.97	0.94	0.1
Long Term Debt Total	-0.58	-0.56	0.08	0.4	-0.1	-0.42	-0.57	0.05	-0.14	-0.6	-0.56	0.63	-0.38	0.06	-0.33	-0.67		-0.61	0.5	0.62	-0.54	-0.57	-0.28
Capital Surpluse	0.71	0.5	0.15	-0.44	-0.3	0.82	0.83	-0.18	0.49	0.72	0.71	-0.71	0.19	0.32	0.72	0.58	-0.61		-0.69	-0.84	0.6	0.62	0.56
Deferred Long Term Liab	-0.69	-0.58	-0.06	0.46	-0.03	-0.59	-0.66	0.12	-0.33	-0.71	-0.65	0.71	-0.19	-0.17	-0.61	-0.66	0.5	-0.69		0.81	-0.7	-0.71	-0.35
Short Long Term Debt	-0.89	-0.74	-0.07	0.61	-0.07	-0.74	-0.82	0.16	-0.41	-0.9	-0.81	0.88	-0.2	-0.2	-0.77	-0.84	0.62	-0.84	0.81		-0.87	-0.88	-0.43
Net Invested Capital	0.92	0.89	0.26	-0.67	0.42	0.46	0.51	-0.15	0.25	0.94	0.67	-0.77	0.18	0.11	0.47	0.97	-0.54	0.6	-0.7	-0.87		0.98	0.24
Net Working Capital	0.96	0.82	0.17	-0.6	0.29	0.55	0.56	-0.22	0.41	0.97	0.69	-0.8	0.15	0.1	0.56	0.94	-0.57	0.62	-0.71	-0.88	0.98		0.37
Capital Stock	0.43	-0.12	-0.46	0.2	-0.67	0.62	0.4	-0.06	0.92	0.42	0.46	-0.4	-0.04	0.18	0.58	0.1	-0.28	0.56	-0.35	-0.43	0.24	0.37

Click cells to compare fundamentals

Apyx Price To Sales Historical Pattern

Today, most investors in Apyx Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Apyx Medical's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's price to sales growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Apyx Medical price to sales as a starting point in their analysis.

Apyx Medical Price To Sales

Timeline

The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.

Competition

Predict Apyx Medical

Price To Sales Ratio Over Time

Apyx Price To Sales Ratio

Price To Sales Ratio

1.65

At this time, Apyx Medical's Price To Sales Ratio is fairly stable compared to the past year.

Based on the latest financial disclosure, Apyx Medical has a Price To Sales of 1.0902 times. This is 94.91% lower than that of the Health Care Equipment & Supplies sector and 77.19% lower than that of the Health Care industry. The price to sales for all United States stocks is 90.45% higher than that of the company.

Apyx Price To Sales Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Apyx Medical's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Apyx Medical could also be used in its relative valuation, which is a method of valuing Apyx Medical by comparing valuation metrics of similar companies.

Apyx Medical is currently under evaluation in price to sales category among its peers.

Apyx Fundamentals

	Return On Equity	-1.1
	Return On Asset	-0.22
	Profit Margin	(0.58) %
	Operating Margin	(0.46) %
	Current Valuation	63.54 M
	Shares Outstanding	37.64 M
	Shares Owned By Insiders	16.18 %
	Shares Owned By Institutions	40.43 %
	Number Of Shares Shorted	230.25 K
	Price To Earning	4.04 X
	Price To Book	4.77 X
	Price To Sales	1.09 X
	Revenue	52.35 M
	Gross Profit	29.13 M
	EBITDA	(18.11 M)
	Net Income	(18.85 M)
	Cash And Equivalents	20.06 M
	Cash Per Share	0.58 X
	Total Debt	38.5 M
	Debt To Equity	0.02 %
	Current Ratio	4.45 X
	Book Value Per Share	0.77 X
	Cash Flow From Operations	(5.25 M)
	Short Ratio	5.49 X
	Earnings Per Share	(0.82) X
	Price To Earnings To Growth	(0.58) X
	Target Price	2.83
	Number Of Employees	252
	Beta	1.21
	Market Capitalization	53.45 M
	Total Asset	79.24 M
	Retained Earnings	(54.45 M)
	Working Capital	57.62 M
	Current Asset	10.01 M
	Current Liabilities	2.45 M
	Net Asset	79.24 M

About Apyx Medical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Apyx Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Apyx Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Apyx Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Apyx Stock Analysis

When running Apyx Medical's price analysis, check to measure Apyx Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apyx Medical is operating at the current time. Most of Apyx Medical's value examination focuses on studying past and present price action to predict the probability of Apyx Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apyx Medical's price. Additionally, you may evaluate how the addition of Apyx Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC